CTOR
Financials
- Market Capitalization 63.23 M
- Employee N/A
- Founded 2021
- CEO N/A
- Website www.citiusonc.com
- Headquarter Delaware, United States
- FIGI BBG01163HKY3
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3993 |  CPIX Cumberland Pharmaceuticals Inc. - Common Stock | 6.63 USD | +1.38% | +6.76% | +17.97% | +85.20% | 99.34 M USD | ||
| 4153 |  TLPH Talphera, Inc. - Common Stock | 1.39 USD | -2.11% | +11.20% | +52.75% | +230.95% | 72.14 M USD | ||
| 4273 |  INCR Intercure Ltd. - ordinary shares | 0.98 USD | +3.16% | +1.03% | +8.89% | -36.77% | 53.59 M USD | ||
| 4346 |  SCYX SCYNEXIS, Inc. - Common Stock | 4.62 USD | +3.13% | +1.32% | +8.71% | +470.37% | 45.88 M USD |
Frequently asked questions about Citius Oncology, Inc. - Common Stock
What is the Citius Oncology, Inc. - Common Stock stock price today?
The current price of Citius Oncology, Inc. - Common Stock (CTOR) is 0.68. Over the past 24 hours, the stock has changed by -2.86%. Follow the CTOR chart for real-time price dynamics.
What is the stock ticker of Citius Oncology, Inc. - Common Stock?
Citius Oncology, Inc. - Common Stock trades under the ticker CTOR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Citius Oncology, Inc. - Common Stock stock going up?
CTOR has changed by -4.23% over the last week, +3.03% over the last month, and -41.38% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Citius Oncology, Inc. - Common Stock net income for the last quarter?
Citius Oncology, Inc. - Common Stock reported net income of -26.61 M for the last quarter. The previous quarter showed -5.53 M, which means net income changed by -380.83%.
How can I buy Citius Oncology, Inc. - Common Stock stock?
You can buy Citius Oncology, Inc. - Common Stock (CTOR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Citius Oncology, Inc. - Common Stock stock?
Investing in Citius Oncology, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTOR chart and related analysis on metatrader.com as part of your research.